Compelling Benefit of Soluble Suppression of Tumorigenicity-2 in Post-Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic.
作者信息
Díez Javier, Bayes-Genis Antoni
机构信息
Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra, Pamplona, Spain
Department of Cardiology and Cardiac Surgery, University Clinic, University of Navarra, Pamplona, Spain.
出版信息
J Am Heart Assoc. 2017 Oct 20;6(10):e007665. doi: 10.1161/JAHA.117.007665.
Abstract
摘要
相似文献
1
Compelling Benefit of Soluble Suppression of Tumorigenicity-2 in Post-Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic.可溶性肿瘤抑制因子2在心肌梗死后风险评估中的显著益处：是时候在临床中常规使用它了。
J Am Heart Assoc. 2017 Oct 20;6(10):e007665. doi: 10.1161/JAHA.117.007665.
2
Short-Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST-Segment Elevation Acute Coronary Events.短期暴露于细颗粒物空气污染优先与ST段抬高型急性冠脉事件风险相关。
J Am Heart Assoc. 2015 Dec 8;4(12):e002506. doi: 10.1161/JAHA.115.002506.
3
Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J-PCI Registry.血栓抽吸在急性冠状动脉综合征患者中的应用：来自全国 J-PCI 注册登记研究的启示。
J Am Heart Assoc. 2022 Aug 16;11(16):e025728. doi: 10.1161/JAHA.122.025728. Epub 2022 Aug 10.
4
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.常规有创策略下的血管造影时机与非 ST 段抬高型急性冠脉综合征的长期预后：FRISC II（不稳定型冠状动脉疾病时的磺达肝癸钠和早期血运重建）、ICTUS（不稳定型冠状动脉综合征的有创与保守治疗）和 RITA-3（不稳定型心绞痛或非 ST 段抬高型心肌梗死患者介入与保守治疗策略）这三项试验的个体化患者数据的协作分析。
JACC Cardiovasc Interv. 2012 Feb;5(2):191-9. doi: 10.1016/j.jcin.2011.10.016.
5
Electrocardiograms in patients with ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and Takotsubo syndrome.
Int J Cardiol. 2015 Dec 15;201:60. doi: 10.1016/j.ijcard.2015.08.026. Epub 2015 Aug 5.
6
Serum chitotriosidase activity in acute coronary syndrome.急性冠状动脉综合征患者血清几丁质酶活性。
J Atheroscler Thromb. 2013;20(2):134-41. doi: 10.5551/jat.13920. Epub 2012 Sep 18.
7
Acute Coronary Syndrome and ST Segment Monitoring.急性冠状动脉综合征与ST段监测
Crit Care Nurs Clin North Am. 2016 Sep;28(3):347-55. doi: 10.1016/j.cnc.2016.04.006. Epub 2016 Jun 22.
8
Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?不稳定型心绞痛/非ST段抬高型心肌梗死、ST段抬高型心肌梗死及经皮冠状动脉介入治疗中的口服抗血小板治疗：是时候更新指南了吗？
Am J Cardiol. 2009 Sep 7;104(5 Suppl):4C-8C. doi: 10.1016/j.amjcard.2009.06.019.
9
Common coronary artery occlusions in patients with myocardial infarction.心肌梗死患者常见的冠状动脉闭塞。
Pan Afr Med J. 2022 Aug 5;42:254. doi: 10.11604/pamj.2022.42.254.34762. eCollection 2022.
10
Treatment of acute coronary syndrome: Part 1: Non-ST-segment acute coronary syndrome.急性冠状动脉综合征的治疗：第 1 部分：非 ST 段抬高型急性冠状动脉综合征。
Crit Care Med. 2011 Oct;39(10):2346-53. doi: 10.1097/CCM.0b013e31821e855f.
引用本文的文献
1
Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases.生长刺激表达基因2（ST2）：在心血管相关疾病中的临床研究与应用
Front Cardiovasc Med. 2022 Nov 4;9:1007450. doi: 10.3389/fcvm.2022.1007450. eCollection 2022.
2
Early sST2 Liberation after Implantation of a Left Ventricular Assist Device in Patients with Advanced Heart Failure.晚期心力衰竭患者植入左心室辅助装置后早期可溶性生长刺激表达基因2蛋白的释放
J Immunol Res. 2020 Dec 26;2020:5826176. doi: 10.1155/2020/5826176. eCollection 2020.
3
Altered mRNA Expression of Interleukin-1 Receptors in Myocardial Tissue of Patients with Left Ventricular Assist Device Support.左心室辅助装置支持患者心肌组织中白细胞介素-1受体的mRNA表达改变
J Clin Med. 2021 Oct 22;10(21):4856. doi: 10.3390/jcm10214856.
本文引用的文献
1
Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2.社区人群心肌梗死后当代风险分层：评分表现和可溶性肿瘤抑制物-2 的增量价值。
J Am Heart Assoc. 2017 Oct 20;6(10):e005958. doi: 10.1161/JAHA.117.005958.
2
The Role of Inflammation in Cardiovascular Outcome.炎症在心血管结局中的作用。
Curr Atheroscler Rep. 2017 Mar;19(3):11. doi: 10.1007/s11883-017-0646-1.
3
The IL-33/ST2 axis: Role in health and disease.IL-33/ST2 轴：在健康和疾病中的作用。
Cytokine Growth Factor Rev. 2015 Dec;26(6):615-23. doi: 10.1016/j.cytogfr.2015.07.017. Epub 2015 Jul 28.
4
Using ST2 in cardiovascular patients: a review.心血管疾病患者中可溶性生长刺激表达基因2蛋白（ST2）的应用：综述
Future Cardiol. 2014 Jul;10(4):525-39. doi: 10.2217/fca.14.36.
5
Heart failure risk prediction models: what have we learned?心力衰竭风险预测模型：我们学到了什么？
JACC Heart Fail. 2014 Oct;2(5):437-9. doi: 10.1016/j.jchf.2014.05.006. Epub 2014 Sep 3.
6
Soluble ST2 serum concentration and renal function in heart failure.可溶性 ST2 血清浓度与心力衰竭患者的肾功能。
J Card Fail. 2013 Nov;19(11):768-75. doi: 10.1016/j.cardfail.2013.09.005.
7
Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results.半乳糖凝集素-3 和可溶性 ST2 用于慢性心力衰竭的生物学变异：对检测结果解读的影响。
Am Heart J. 2013 Jun;165(6):995-9. doi: 10.1016/j.ahj.2013.02.029. Epub 2013 Apr 6.
8
Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.白细胞介素-33/ST2 系统的组成部分在人心肌细胞和心脏脉管系统细胞中呈现差异表达和调控。
J Mol Cell Cardiol. 2013 Jul;60:16-26. doi: 10.1016/j.yjmcc.2013.03.020. Epub 2013 Apr 6.
9
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.《2013年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
10
Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay.通过三种不同的市售检测方法（MBL ST2检测法、Presage ST2检测法和R&D ST2检测法）测定的可溶性ST2血浆浓度的比较。
Clin Chim Acta. 2012 Oct 9;413(19-20):1493-4. doi: 10.1016/j.cca.2012.06.021. Epub 2012 Jun 20.
Zotero 插件